Drug Delivery · 2018 · 43 citations · 22 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanomaterialsNanoparticle Drug DeliveryCancer Drug DeliveryCancer NanomedicineDrug EncapsulationNanomedicineNanoparticle Delivery SystemsNanoparticle FormulationsAnticancer ActivityAnticancer ChemotherapyBreast Cancer ChemotherapyCancer NanotherapyChemical CrosslinkingMultifunctional NanoparticlesNanoparticle CytotoxicityPolymeric Nanoparticle Formulation
. When systemically administered in a mouse xenograft model for human breast cancer, the HSA-PEG-based nanoparticle formulation exhibited an extended systemic circulation for more than 96 h and enhanced intratumoral accumulation, resulting in a remarkable anticancer effect and prolonged survival of the animals.
22
Neil Desai, Vuong Trieu, Zhiwen Yao et al. · Clinical Cancer Research · 2006 · 1.2K citations
Medicine, Oncology, Pharmacology +14